Forty-three thousand active community health center patients had 83,542 Pap smears between January 1, 1997, and December 31, 2010; 213 women (0.26%) were diagnosed with AGC. Of our entire registry of ...

Cervical cancer is the second most common malignancy in women worldwide. It is generally accepted that the development of cervical cancer from precancers (CIN2/3) involves multistep molecular changes ...

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial. The shot ...

In Italy, many women with cervical intraepithelial neoplasia (CIN) undergo hysterectomy despite the fact that guidelines advise against it. In fact, over the past 10 years, there has been at least a ...

Vulval cancer predominantly affects postmenopausal women. A smaller proportion of vulval cancers, particularly at older ages, are now thought to be associated with human papillomavirus infection than ...

Both complete and incomplete vaccination in individuals were associated with a significantly lower detection rate of high-risk HPV 16/18 and 16/18/31/33/45 in CIN2 compared with no vaccination.

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study Infections with a high-risk human papillomavirus ...

The Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I and II trials evaluated efficacy of the quadrivalent human papillomavirus (HPV) recombinant Gardasil. In the FUTURE II ...

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. A cross-sectional study was performed in 161 patients referred for an abnormal cervical ...

Illustrative picture of human papillomavirus (HPV) vaccine. Credit: Getty Images. Primary care providers have a critical role in human papillomavirus (HPV) screening and prevention. Human ...

A therapeutic vaccine eradicated human papillomavirus (HPV) in a fourth of women with precancerous cervical lesions, a placebo-controlled clinical trial showed. Overall, the subcutaneously ...